Search Results - "Wysokinski, W E"

Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients by Tafur, A.J., Wysokinski, W.E., McBane, R.D., Wolny, E., Sutkowska, E., Litin, S.C., Daniels, P.R., Slusser, J.P., Hodge, D.O., Heit, J.A.

“…Patients with active cancer are often on chronic anticoagulation and frequently require interruption of this treatment for invasive procedures. The impact of…”
Get full text

Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis by WYSOKINSKA, E. M, WYSOKINSKI, W. E, BROWN, R. D, KARNICKI, K, GOSK-BEIRSKA, I, GRILL, D, MCBANE, R. D

“…To characterize differences in the prevalence of thrombophilic variables in a large cohort of patients with cerebral venous sinus thrombosis (CVST) and lower…”
Get full text

Predictors of major bleeding in peri‐procedural anticoagulation management by TAFUR, A. J., McBANE, R., WYSOKINSKI, W. E., LITIN, S., DANIELS, P., SLUSSER, J., HODGE, D., BECKMAN, M. G., HEIT, J. A.

“…Background: Appropriate periprocedural management for chronically anticoagulated patients requires assessment of patient‐specific thrombosis and bleeding…”
Get full text

Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi by Wysokinski, W. E., Owen, W. G., Fass, D. N., Patrzalek, D. D., Murphy, L., Mcbane, R. D.

“…Background/objective: Thromboembolism secondary to atrial fibrillation accounts for approximately one‐fourth of all strokes. Although considerable resources…”
Get full text

Intermittent pneumatic compression in stable claudicants: effect on hemostasis and endothelial function by Sutkowska, E, Wozniewski, M, Gamian, A, Gosk-Bierska, I, Alexewicz, P, Sutkowski, K, Wysokinski, W E

“…Intermittent pneumatic compression (IPC) increases systemic fibrinolytic activity but may also injure endothelial cells and thereby induce coagulation. The…”
Get more information

Association between P-selectin levels and left atrial blood stasis in patients with nonvalvular atrial fibrillation by Wysokinski, W.E., Cohoon, K.P., Melduni, R.M., Mazur, M., Ammash, N., Munger, T., Konik, E., McLeod, T., Gosk-Bierska, Izabeal, McBane, R.D.

“…P-selectin - a biomarker of platelet and endothelial cell activation is elevated in patients with non-valvular atrial fibrillation (NVAF). However, the…”
Get full text

Prevalence of lower extremity venous disease in inflammatory bowel disease by Gosk-Bierska, I, McBane, R D, Waszczuk, E, Paradowski, L, Wysokinski, W E

“…Inflammatory bowel disease (IBD) has long been considered a risk factor for venous thromboembolism (VTE). Whereas most patients have persistent venous valvular…”
Get more information

Coagulation in diabetic and non-diabetic claudicants by Gosk-Bierska, I, Adamiec, R, Alexewicz, P, Wysokinski, W E

“…In order to compare hemostasis in diabetic and non-diabetic claudicants we evaluated endothelial (von Willebrand factor, vWF), rheologic (fibrinogen,…”
Get more information

Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study by Perez Botero, J, Ormsby, W.D, Ashrani, A.A, McBane, R.D, Wysokinski, W.E, Patnaik, M.M, Lewis, B.R, Grill, D.E, Pruthi, R.K, Heit, J.A

“…Abstract Introduction While Factor V Leiden ( F5 rs6025 A allele) is a known venous thromboembolism (VTE) risk factor, VTE risk among heterozygous vs…”
Get full text

Predicting superficial venous incompetence with strain gauge plethysmography by Skeik, N, Kalsi, H, Wysokinski, W E, Heaser, T V, Wennberg, P W

“…With currently available effective interventional methods to treat superficial venous insufficiency, it becomes particularly important to have a simple and…”
Get more information

Iliac vein thrombosis: feasibility assessment of randomized controlled trials of endovascular pharmacomechanical thrombolysis by WYSOKINSKA, E. M., SOBANDE, F., WYSOKINSKI, W. E., BJARNASON, H., McBANE II, R. D.

“…Background: Optimal treatment for iliac vein thrombosis has not been established by randomized clinical trials largely owing to difficulty in patient…”
Get full text

Antithrombotic action of endogenous porcine protein C activated with a latent porcine thrombin preparation by McBane, R D, Wysokinski, W E, Chesebro, J H, Owen, W G

“…Endogenously activated protein C is evaluated for antithrombotic activity in porcine carotid arteries subjected to mechanical trauma. Protein C is activated by…”
Get more information

Sustained Classic Clinical Spectrum of Thromboangiitis Obliterans (Buerger's Disease) by Wysokinski, Waldemar E., Kwiatkowska, Wieslawa, Sapian-Raczkowska, Bozena, Czarnacki, Maciej, Doskocz, Romana, Kowal-Gierczak, Barbara, Wysokinski, Waldemar E.

“…Thromboangiitis obliterans (TAO) has been reported to become less common in general population but more common in women, and in elderly patients. The authors…”
Get full text

Individual Propensity for Arterial Thrombosis by Wysokinski, Waldemar E, McBane, Robert D, Owen, Whyte G

“…Arterial thrombophilia independent of vascular pathology has not been previously defined either experimentally or epidemiologically. To address the existence…”
Get full text

Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation? by Wysokinski, W E, Spittell, P C, Pellikka, P A, Miller, W L, Seward, J B

“…This study was designed to evaluate the effect of short-term administration of graded dose of dobutamine on the circulation of the lower limbs in the patients…”
Get more information

Buerger's disease in two brothers: iliac artery occlusion by thromboangiitis obliterans--case reports by Wysokinski, W E, Kwiatkowska, W, Maslowski, L, Witkiewicz, W, Kowal-Gierczak, B

“…Several characteristics of thromboangiitis obliterans are unique and confirm the existence of the disease as a distinct pathological entity. Its predilection…”
Get more information

Pulmonary artery capacitance a simple and novel prognostic variable in acute pulmonary embolism by Quintero-Martinez, J A, Cordova, S N, Alam, M M, Jain, V, Vlazny, D T, Houghton, D E, Casanegra, A I, Wysokinski, W E, Villarraga, H R

“…Abstract Background The non-invasive calculation of right ventricular hemodynamics such as the pulmonary artery capacitance (PAC) has proven to be feasible and…”
Get full text

P970Influence of diabetes mellitus on survival of patients with atrial fibrillation - A population-based study by Patlolla, S H, Lee, H C, Gersh, B J, Wysokinski, W E, Melduni, R M

Get full text

Platelet factor XIII gene expression and embolic propensity in atrial fibrillation by Gosk-Bierska, Izabella, McBane, Robert D, Wu, Yanhong, Mruk, Jozef, Tafur, Alfonso, McLeod, Thomas, Wysokinski, Waldemar E

“…Nearly 15% of patients with non-valvular atrial fibrillation (NVAF) have left atrial appendage thrombus (LAAT) by transesophageal echocardiography (TEE) and…”
Get more information

Peripheral necrosis of hind legs of rabbits immunized with elastin by Wysokinski, W E

Get more information